T5	Treatment 2 18	CFTR potentiator
T7	Sub-Disorder 36 51;60 74	cystic fibrosis G551D mutation
T9	Drug 2 18	CFTR potentiator
T6	Subject 22 75	patients with cystic fibrosis and the G551D mutation.
